Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning.
Queiro R, Seoane-Mato D, Laiz A, Agirregoikoa EG, Montilla C, Park HS, Pinto-Tasende JA, Bethencourt Baute JJ, Ibáñez BJ, Toniolo E, Ramírez J, García AS; Proyecto REAPSER Study Group. Queiro R, et al. Arthritis Res Ther. 2022 Jun 24;24(1):153. doi: 10.1186/s13075-022-02838-2. Arthritis Res Ther. 2022. PMID: 35751091 Free PMC article.
Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2 - Management of Special Populations, Patients With Comorbid Conditions, and Risk.
Carrascosa JM, Puig L, Romero IB, Salgado-Boquete L, Del Alcázar E, Lencina JJA, Moreno D, de la Cueva P. Carrascosa JM, et al. Among authors: romero ib. Actas Dermosifiliogr. 2022 Jun;113(6):583-609. doi: 10.1016/j.ad.2022.01.024. Epub 2022 Feb 11. Actas Dermosifiliogr. 2022. PMID: 35570005 Free article. Review. English, Spanish.
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
Bachelez H, van de Kerkhof PC, Strohal R, Kubanov A, Valenzuela F, Lee JH, Yakusevich V, Chimenti S, Papacharalambous J, Proulx J, Gupta P, Tan H, Tawadrous M, Valdez H, Wolk R; OPT Compare Investigators. Bachelez H, et al. Lancet. 2015 Aug 8;386(9993):552-61. doi: 10.1016/S0140-6736(14)62113-9. Epub 2015 Jun 4. Lancet. 2015. PMID: 26051365 Clinical Trial.